Thomas M Parks

Title: The Innovations of Thomas M Parks

Introduction

Thomas M Parks is a notable inventor based in San Mateo, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. His work has led to the creation of innovative compounds that have the potential to improve health outcomes.

Latest Patents

Thomas M Parks holds a patent for "Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents." This patent describes 1-(4-aminophenyl)pyrazoles that are optionally substituted on the 3- and 5-positions of the pyrazole ring and on the amino group at the 4-position of the phenyl ring. These pyrazoles have been shown to inhibit IL-2 production in T-lymphocytes, showcasing their potential therapeutic applications.

Career Highlights

Parks is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research in the pharmaceutical industry. His work is characterized by a commitment to innovation and the development of new therapeutic agents.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues, including Mary Ann Hoermann and Rajashekhar Betageri. These collaborations have contributed to the success of his research and the advancement of their shared goals in the pharmaceutical field.

Conclusion

Thomas M Parks is a distinguished inventor whose work in anti-inflammatory agents has the potential to make a significant impact in medicine. His innovative approach and dedication to research continue to drive advancements in the pharmaceutical industry.